Insiders · GRCE

GRCE insider transactions

Grace Therapeutics Inc. (GRCE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for GRCE

• 6d
  Large owner Opaleye Management Inc. bought $24,206 worth of shares (11,608 units at $2.09) (SEC Form 4)

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 225d
  SEC Form 4 filed by Director Kavuru Vimal

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 225d
  SEC Form 4 filed by Director Neugeboren Edward

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 225d
  SEC Form 4 filed by Director Davis A Brian

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 225d
  SEC Form 4 filed by Director Kottayil George

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 469d
  SEC Form 4 filed by Director Kottayil George

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 469d
  SEC Form 4 filed by Director Davis A Brian

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 469d
  SEC Form 4 filed by Director Kavuru Vimal

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 469d
  SEC Form 4 filed by Director Neugeboren Edward

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 496d
  SEC Form 4 filed by Chief Medical Officer Macdonald R. Loch

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 496d
  SEC Form 4 filed by VP Program Management Kumar Amresh

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 496d
  SEC Form 4 filed by VP Clinical Operations D'Andrea Carrie

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 496d
  SEC Form 4 filed by Principal Financial Officer Delaversano Robert J

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)
• 496d
  SEC Form 4 filed by Chief Executive Officer Kohli Prashant

  4 - Grace Therapeutics, Inc. (0001444192) (Issuer)